Therapeutic Asset Ratings
230 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
aur103
Solid Tumor, Adult
Aurigene Discovery Technologies Limited
P1
C
(37)
aur105
Solid Tumor, Adult
Aurigene Discovery Technologies Limited
P1
C
(37)
Avutometinib
Solid Tumor, Adult
Memorial Sloan Kettering Cancer Center
P1
C
(37)
Axn-2510
Solid Tumor, Adult
Axion Bio, Inc
P1
C
(37)
AZD0240
Solid Tumor, Adult
AstraZeneca
P1
C
(37)
azd0240: autologous, engineered t cells targeting kras g12d
Solid Tumor, Adult
AstraZeneca
P1
C
(37)
azd1390
Solid Tumor, Adult
Memorial Sloan Kettering Cancer Center
P1
C
(37)
Bbo-10203
Solid Tumor, Adult
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1
C
(37)
Bbo-11818
Solid Tumor, Adult
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1
C
(37)
Belzutifan
Solid Tumor, Adult
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
P1
C
(37)
Benzamide, N-[(3R)-3-(2-chloro-5-fluorophenyl)-6-(5-cyano[1,2,4]triazolo[1,5-a]pyridin-6-yl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-3-fluoro-5-(trifluoromethyl)-
Solid Tumor, Adult
Relay Therapeutics, Inc.
P1
C
(37)
Bgb-24714
Solid Tumor, Adult
BeiGene
P1
C
(37)
bh009
Solid Tumor, Adult
Zhuhai Beihai Biotech Co., Ltd
P1
C
(37)
Binimetinib
Solid Tumor, Adult
Pierre Fabre Medicament
P1
C
(37)
Bio-008
Solid Tumor, Adult
Shijiazhuang Yiling Pharmaceutical Co. Ltd
P1
C
(37)
Blinatumomab
Solid Tumor, Adult
Imugene Limited
P1
C
(37)
Bl-M17D1
Solid Tumor, Adult
SystImmune Inc.
P1
C
(37)
bp1001-a
Solid Tumor, Adult
Bio-Path Holdings, Inc.
P1
C
(37)
by101921 tablets
Solid Tumor, Adult
Chengdu Baiyu Pharmaceutical Co., Ltd.
P1
C
(37)
Capivasertib
Solid Tumor, Adult
National University Hospital, Singapore
P1
C
(37)
CF33-CD19
Solid Tumor, Adult
Imugene Limited
P1
C
(37)
cf33-hnis
Solid Tumor, Adult
Imugene Limited
P1
C
(37)
Chimeric Antigen Receptor Modified T Cells Infusion
Solid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University
P1
C
(37)
CIS-DIAMMINEDICHLOROPLATINUM II
Solid Tumor, Adult
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
P1
C
(37)
CRX100
Solid Tumor, Adult
BioEclipse Therapeutics
P1
C
(37)
Showing 126 to 150 of 230 assets
Previous
Page 6 of 10
Next